Solara Active Pharma Sciences has incorporated wholly-owned subsidiary in the name of ‘Synthix Global Pharma Solutions’ is on April 29, 2025. The wholly- owned subsidiary is being incorporated in relation to proposed demerger of the CRAMS and polymers business into an independent entity.
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer.